Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268063
Max Phase: Preclinical
Molecular Formula: C44H41ClN8O7S
Molecular Weight: 861.38
Associated Items:
ID: ALA5268063
Max Phase: Preclinical
Molecular Formula: C44H41ClN8O7S
Molecular Weight: 861.38
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)c1ccc(COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
Standard InChI: InChI=1S/C44H41ClN8O7S/c1-23-24(2)61-44-36(23)38(27-13-15-29(45)16-14-27)48-31(39-51-50-25(3)52(39)44)21-35(55)46-19-4-5-20-47-40(56)28-11-9-26(10-12-28)22-60-33-8-6-7-30-37(33)43(59)53(42(30)58)32-17-18-34(54)49-41(32)57/h6-16,31-32H,4-5,17-22H2,1-3H3,(H,46,55)(H,47,56)(H,49,54,57)/t31-,32?/m0/s1
Standard InChI Key: GSUSWGRLBKUPJT-CYZZXXEPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 861.38 | Molecular Weight (Monoisotopic): 860.2507 | AlogP: 5.50 | #Rotatable Bonds: 13 |
Polar Surface Area: 194.05 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.44 | CX LogP: 4.54 | CX LogD: 4.53 |
Aromatic Rings: 5 | Heavy Atoms: 61 | QED Weighted: 0.10 | Np Likeness Score: -0.87 |
1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S.. (2023) Design, synthesis, and biological evaluation of BRD4 degraders., 78 [PMID:36563515] [10.1016/j.bmc.2022.117134] |
Source(1):